Interferon-gamma (IFN-γ) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats

Clinical and Experimental Immunology

Volumn 103, Issue 2, 1996, Pages 212-218

  Johansen, H K ^a   Hougen, H P ^b   Rygaard, J ^c   Hoiby N ^a,b  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Mental Health Center Glostrup   (Denmark)

Author keywords

Cystic fibrosis; IFN treatment; Pseudomonas aeruginosa; Th1 like

Indexed keywords

ALGINIC ACID; RECOMBINANT GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HISTOPATHOLOGY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT; T LYMPHOCYTE SUBPOPULATION;

EID: 0030059428     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-618.x     Document Type: Article

References (36)

1. Wine JJ. Basic aspects of cystic fibrosis. Clin Rev Allergy 1991;9:1-28.
2. Pedersen SS. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS 1992; 100:1-79.
3. Kharazmi A, Schiøtz PO, Høiby N, Bæk L, Döring G. Demonstration of neutrophil chemotactic activity in the sputum of cystic fibrosis patients with Pseudomonas aeruginosa infection. Eur J Clin Invest 1986; 16:143-8.
4. Döring G, Bellon G, Knight R. Immunology of cystic fibrosis. In: Hodson ME, Geddes DM, eds. Cystic fibrosis, Vol. 1. London: Chapman & Hall Medical, 1995:99-129.
5. Høiby N. Microbiology of cystic fibrosis. In: Hodson ME, Geddes DM, eds. Cystic fibrosis. Vol. 1. London: Chapman & Hall Medical, 1995:75-98.
6. Dean TP, Dai Y, Shute JK, Church MK, Warner JO. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr Res 1993; 34:159-61.
7. Inoue H, Massion PP, Ueki IF et al. Pseudomonas stimulates interleukin-8 mRNA expression selectively in airway epithelium, in gland ducts, and in recruited neutrophils. Am J Respir Cell Mol Biol 1994; 11:651-63.
8. 4 production by leukocytes in patients with cystic fibrosis. Prostaglandins Leukotrienes and Essential Fatty Acids 1994; 51:407-10.
9. Rasmussen JM. Inherited deficiencies of complement proteins. APMIS 1991; 99:1-48.
10. McElvaney NG, Doujaiji B, Moan MJ et al. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis. Am Rev Respir Dis 1993; 148:1056-60.
11. Cain TK, Rank RG. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 1995; 63:1784-9.
12. Yamahura M, Uyemura K, Deans RJ et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254:277-9.
13. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989; 7:145-73.
14. Kemp M, Kurtzhals JAL, Bendtzen K et al. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect Immun 1993; 61:1069-73.
15. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. APMIS 1995; 103:161-79.
16. Cryz Jr SJ, Fürer E, Que JU. Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine. Infect Immun 1991; 59: 45-50.
17. Moss RB, Hsu Y-P, Yssel H. Is CF a Th2 immunoinflammatory disease? Abstract Seventh Annual North American Cystic Fibrosis Conference. Dallas, Texas, USA: Pediatr Pulmonol, Suppl. 8:289.
18. Johansen HK, Hougen HP, Cryz Jr SJ, Rygaard J, Høiby N. Vaccination changes inflammation and improves survival in chronic P. aeruginosa pneumonia in rats. Am J Respir Crit Care Med 1995; 152:1337-46.
19. Johansen HK, Espersen F, Cryz Jr SJ et al. Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection. Infect Immum 1994; 62:3146-55.
20. Johansen HK, Espersen F, Pedersen SS et al. Pseudomonas aeruginosa lung infection in normal and athymic rats. APMIS 1993; 101:207-25.
21. Benedetto N, Auriault C, Darcy F et al. Effect of rIFN-gamma and IL-2 treatments in mouse and nude rat infections with Toxoplasma gondii. Eur Cytokine Net 1991; 2:107-14.
22. Gallin JI. Interferon-gamma in the management of chronic granulomatous disease. Rev Infect Dis 1991; 13: 973-8.
23. Joly V, Saint-Julien L, Carbon C, Yeni P. In vivo activity of interferon-gamma in combination with amphotericin B in the treatment of experimental cryptoccosis. J Infect Dis 1994; 170: 1331-4.
24. Murray HW. Gamma interferon, cytokine-induced macrophage activation, and anti-microbial host defense. Diagn Microbiol Infect Dis 1990; 134:411-21.
25. Hagen TLM, Vianen von W, Bakker-Woudenberg IAJM. Modulation of non-specific antimicrobial resistance of mice to Klebsiella pneumoniae septicemia by liposome-encapsulated muramyl tripeptide phosphalidylethanolamine and interferon-gamma alone or combined. J Infect Dis 1995; 171:385-92.
26. Pierangeli SS, Polk HC, Parmely MJ, Sonnenfeld G. Murine interferon-gamma enhances resistance to infection with strains of Pseudomonas aeruginosa in mice. Cytokine 1993; 5:230-4.
27. Ijzermans JNM, Bouwman E, Bijma A et al. Immunomodulation by recombinant rat interferon-gamma in vivo J Interferon Res 1990; 10:203-11.
28. Dunkley M, Pabst R, Cripps A. An important role for intestinally derived T cells in respiratory defence. Immunol Today 1995; 16:231-6.
29. Pedersen PS, Flensborg EW, Johnsen SG. Urinary 17-ketosteroids in cystic fibrosis. Acta Paediatr Scand 1981; 70:507-12.
30. Rook GAW, Hernandez-Pando R, Lightman SL. Hormones. Peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 1994; 15:301-3.
31. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994; 15:575-81.
32. Koller DY, Götz M, Eichler I, Urbanek R. Eosinophilic activation in cystic fibrosis. Thorax 1994; 49:496-9.
33. Reimert CM, Giwercman B, Høiby N, Kharazmi A. Eosinophil cationic protein in sputum from cystic fibrosis patients with Pseudomonas aeruginosa infections. Lancet 1994; 344:1504-5.
34. Suter S, Schaad UB, Roux-Lombard P et al. Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis. Am Rev Resp Dis 1989; 140:1640-4.
35. 4 concentrations and more severe pulmonary disease. J Allergy Clin Immunol 1994; 94:100-7.
36. Kaufmann SHE. Interleukins, Mycobacteria, and Listeria. Diagn Microbiol Infect Dis 1990; 13:429-33.